Approvals/TGA/ONBEVZI bevacizumab 100 mg/4mL concentrated injection for intravenous infusion vial

Approved

STANDARD

ONBEVZI bevacizumab 100 mg/4mL concentrated injection for intravenous infusion vial

Samsung Bioepis AU Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 31b878cb0dee4e6b
Product Name: ONBEVZI bevacizumab 100 mg/4mL concentrated injection for intravenous infusion vial
Artg Id: 431837
Artg Name: ONBEVZI bevacizumab 100 mg/4mL concentrated injection for intravenous infusion vial
Sponsor: Samsung Bioepis AU Pty Ltd
Company Detail Path: /organization/samsung-bioepis-au-pty-ltd
Artg Date: 2024-01-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

31b878cb0dee4e6b

Type

Standard